logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5610.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5610.produseast1
Showing 1 - 3 of 3 Items
Showing 1 - 3 of 3 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Conference Material
|
Slide Presentation

Operational feasibility and acceptability of the addition of R21 malaria vaccine and intermittent preventive therapy for children to existing malaria control initiatives in Kule, Ethiopia

Girma Y, Lavilla KM, Tassawar A, Siferaw K, Koang D,  et al.
2025-05-22 • MSF Scientific Days International 2025
2025-05-22 • MSF Scientific Days International 2025
Conference Material
|
Abstract

Operational feasibility and acceptability of the addition of R21 malaria vaccine and intermittent preventive therapy for children to existing malaria control initiatives in Kule, Ethiopia

Girma Y, Lavilla KM, Tassawar A, Siferaw K, Koang D,  et al.
2025-05-22 • MSF Scientific Days International 2025
2025-05-22 • MSF Scientific Days International 2025
Journal Article
|
Research

"Stopping the itch": mass drug administration for scabies outbreak control covered for over nine million people in Ethiopia

Enbiale W, Baynie TB, Ayalew A, Gebrehiwot TG, Getanew T,  et al.
2020-06-29 • Journal of Infection in Developing Countries
2020-06-29 • Journal of Infection in Developing Countries
INTRODUCTION
In 2018, the Ethiopian Ministry of Health embarked on a Mass Drug Administration (MDA) campaign that involved over 9 million people in Ethiopia - the largest scabies MDA...